New Equities Leadership Could Emerge, Drugmakers Pledge to Avoid Safety Shortcuts on Covid Vaccine

We set the Businessweek Agenda and look at market volatility with Bloomberg Intelligence Chief Equity Strategist Gina Martin Adams and Bloomberg Stocks Editor Dave Wilson. Bloomberg Opinion Healthcare Columnist Max Nisen explains how drugmakers racing to produce Covid-19 vaccines have pledged to avoid shortcuts on science as they face pressure to rush a shot to market. Cheryl Cheng, General Partner at Blue Run Ventures, discusses social networking app ZeeMee to help college students stay connected amid the pandemic. Bloomberg News Finance Reporter Michelle Davis shares the details of her story "Dear Wall Street, Your Boss Wants You to Come Back to the Office." Bloomberg New Economy Editorial Director Andy Browne discusses the U.S. scaling back economic ties with China. And we Drive to the Close with Randy Watts, Chief Investment Strategist at O'Neil Global Advisors.

Hosts: Carol Masar and Jason Kelly. Producer: Paul Brennan

See omnystudio.com/listener for privacy information.